Ageing Rewrites Pharma Portfolio Strategy
29 July 2026.
Ageing reshapes pharma portfolios as access, evidence and delivery determine growth
Healthcare & Pharma
Active Pharmaceutical Ingredients (APIs) Market to reach US$529.7bn
23 July 2026.
The global Active Pharmaceutical Ingredients (APIs) market is Projected to grow at a CAGR of 6.6% by 2036
When Vaccine Policy Becomes Market Risk
22 July 2026.
Policy, platforms and manufacturing are reshaping global vaccine market opportunities
Cell & Gene Therapy Manufacturing: The Race to Scale
15 July 2026.
Manufacturing readiness now determines which cell and gene therapies scale
Precision Medicine: Capturing Value
8 July 2026.
Precision medicine shifts value from therapies to diagnostics, evidence and access
Cell & Gene Therapy Manufacturing Market to Reach US$63.0bn
2 July 2026.
The global cell & gene therapy manufacturing market is valued at US$13.7 billion in 2026
Healthcare Moves Home. Pharma Follows
1 July 2026.
Healthcare moves home as pharma’s commercial model shifts toward patients
The Next Pharma Challenge: Treatment Persistence
24 June 2026.
Patient persistence is becoming pharma’s next growth test after launch
The Business of Prevention: Why Pharma Is Moving Upstream
17 June 2026.
Prevention-led pharma growth depends on earlier intervention, access and scale
The Rise of the Micro-Blockbuster
10 June 2026.
Healthcare growth is shifting from standard treatments to personalised patient strategies
Women’s Health Trials: From the Margins to the Mainstream
3 June 2026.
Women’s health trials enter a more evidence-led, higher-value growth phase
Women’s Clinical Trials & CROs Market Report 2026-2036: 8.5% CAGR
27 May 2026.
The global Women’s Clinical Trials & CROs Market is projected to grow at a CAGR of 8.5% by 2036
The Next Phase of Vaccine Growth
27 May 2026.
Vaccines are shifting from prevention into platforms, oncology and manufacturing-led growth
Vaccine Sales Market Report 2026-2036: 6.3% CAGR
22 May 2026.
The global Vaccine Sales market is projected to grow at a CAGR of 6.3% by 2036
Pre-filled Syringes Become Core to Biologics Delivery
20 May 2026.
Pre-filled syringes shift from convenience to strategic biologics delivery platform
Pre-Filled Syringes Market Report 2026-2036: 9.2% CAGR
18 May 2026.
The global Pre-Filled Syringes market is projected to grow at a CAGR of 9.2% by 2036
mRNA Vaccines Market Report 2026-2036
14 May 2026.
mRNA vaccine platforms expand beyond prevention into oncology and immune-mediated diseases
Pharma’s New Backbone: The Distribution Advantage
13 May 2026.
Pharma distribution becomes strategic as speciality medicines reshape access and infrastructure
IoMT in Healthcare: The Move to Continuous, Data-Driven Care
13 May 2026.
IoMT is reshaping healthcare through AI, wearables and connected care.
Beyond the Batch: Pharma Manufacturing Becomes Strategic
6 May 2026.
CDMOs become strategic partners as biologics complexity reshapes pharmaceutical manufacturing
